Becker M - Search Results

1

Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer.

Krafft U, Reis H, Ingenwerth M, Kovalszky I, Becker M, Niedworok C, Darr C, Nyirády P, Hadaschik B, Szarvas T. Krafft U, et al. Among authors: becker m. Pathol Oncol Res. 2020 Jan;26(1):253-261. doi: 10.1007/s12253-018-0447-z. Epub 2018 Jul 17. Pathol Oncol Res. 2020. PMID: 30019121 Free article.

2

Serum levels of angiogenic factors and their prognostic relevance in bladder cancer.

Szarvas T, Jäger T, Droste F, Becker M, Kovalszky I, Romics I, Ergün S, Rübben H. Szarvas T, et al. Among authors: becker m. Pathol Oncol Res. 2009 Jun;15(2):193-201. doi: 10.1007/s12253-008-9107-z. Epub 2008 Sep 20. Pathol Oncol Res. 2009. PMID: 18807212 Free article.

3

Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer.

Szarvas T, Jäger T, Becker M, Tschirdewahn S, Niedworok C, Kovalszky I, Rübben H, Ergün S, vom Dorp F. Szarvas T, et al. Among authors: becker m. Pathol Oncol Res. 2011 Jun;17(2):325-32. doi: 10.1007/s12253-010-9320-4. Epub 2011 Jan 21. Pathol Oncol Res. 2011. PMID: 21253919 Free article.

4

Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer.

Szarvas T, Becker M, vom Dorp F, Gethmann C, Tötsch M, Bánkfalvi A, Schmid KW, Romics I, Rübben H, Ergün S. Szarvas T, et al. Among authors: becker m. Cancer Sci. 2010 May;101(5):1300-8. doi: 10.1111/j.1349-7006.2010.01506.x. Epub 2010 Jan 20. Cancer Sci. 2010. PMID: 20180812 Free PMC article.

5

The prognostic value of cadherin switch in bladder cancer.

Jäger T, Becker M, Eisenhardt A, Tilki D, Tötsch M, Schmid KW, Romics I, Rübben H, Ergün S, Szarvas T. Jäger T, et al. Among authors: becker m. Oncol Rep. 2010 Apr;23(4):1125-32. doi: 10.3892/or_00000741. Oncol Rep. 2010. PMID: 20204300

6

Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer.

Becker M, Szarvas T, Wittschier M, vom Dorp F, Tötsch M, Schmid KW, Rübben H, Ergün S. Becker M, et al. Cancer. 2010 Oct 1;116(19):4502-12. doi: 10.1002/cncr.25326. Cancer. 2010. PMID: 20564745 Free article.

7

Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer.

Szarvas T, Singer BB, Becker M, Vom Dorp F, Jäger T, Szendroi A, Riesz P, Romics I, Rübben H, Ergün S. Szarvas T, et al. Among authors: becker m. BJU Int. 2011 Apr;107(7):1069-73. doi: 10.1111/j.1464-410X.2010.09625.x. Epub 2010 Sep 3. BJU Int. 2011. PMID: 20825402

8

Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.

Szarvas T, Becker M, Vom Dorp F, Meschede J, Scherag A, Bánkfalvi A, Reis H, Schmid KW, Romics I, Rübben H, Ergün S. Szarvas T, et al. Among authors: becker m. Int J Cancer. 2011 Mar 15;128(6):1486-92. doi: 10.1002/ijc.25454. Int J Cancer. 2011. PMID: 20473942

9

[Plasma E-cadherin levels in urinary bladder cancer: does it improve risk stratification?].

Szarvas T, Hoffmann F, Becker M, Schenck M, Vom Dorp F, Rübben H, Jäger T. Szarvas T, et al. Among authors: becker m. Urologe A. 2011 Jan;50(1):64-70. doi: 10.1007/s00120-010-2454-x. Urologe A. 2011. PMID: 21153394 German.

10

[Urine-based markers of angiogenesis in bladder cancer].

Becker M, Tilki D, Szarvas T, Rübben H, Ergün S. Becker M, et al. Urologe A. 2009 Jun;48(6):609-14. doi: 10.1007/s00120-009-1989-1. Urologe A. 2009. PMID: 19557465 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,064 results

Search Page

Filters